Spaulding Rehabilitation Hospital (SRH) exists within the framework of the Mass General Brigham Health System (MGB) and Harvard Medical School (HMS). MGB is among the largest academic health systems in the nation and is the only health system with three institutions ranked in the Top-20 Best…
We are very happy to announce that Abbott has received FDA clearance for what will be the first commercially available laboratory traumatic brain injury (TBI) blood test, making it widely available to hospitals in the United States. The test, which runs on Abbott's Alinity® i laboratory instrument…
BARDA is partnering with Abbott to broaden the company’s current traumatic brain injury (TBI) test that will aid healthcare providers in diagnosing and determining severity of TBI in adults and children.
Blood tests taken within 24 hours of a traumatic brain injury (TBI) flag which patients are likely to die and which patients are likely to survive with severe disability, according to a study headed by UC San Francisco, the University of Pennsylvania and the University of Michigan. Their results…
Traumatic Brain Injury: A Roadmap for Accelerating Progress, a new consensus study report from the National Academies of Sciences, Engineering, and Medicine’s Committee on Accelerating Progress in Traumatic Brain Injury Research and Care, examines how progress can be advanced in TBI care and…
Spaulding Rehabilitation Hospital (SRH) is recruiting a Post-Doctoral Research Fellow to join the SRH Neurorehabilitation Laboratory. The mission of the SRH Neurorehabilitation Laboratory, directed by Dr. Joseph T. Giacino, is to advance the development of more precise methods of assessment,…
